The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | VTRS Viatris Inc | Andrew Cuneo See Remarks | XIn-the-money exercise Restricted Stock Unitsderivative | -4,577 | $0.00 | $0 | 0 | Mar 6, 2023 |
| Mar 2, 2023 | VTRS Viatris Inc | Andrew Cuneo See Remarks | XIn-the-money exercise Restricted Stock Unitsderivative | -17,163 | $0.00 | $0 | 0 | Mar 6, 2023 |
| Mar 2, 2023 | VTRS Viatris Inc | Brian Roman Global General Counsel | XIn-the-money exercise Common Stock | +5,034 | $0.00 | $0 | 63,261 | Mar 6, 2023 |
| Mar 2, 2023 | VTRS Viatris Inc | Brian Roman Global General Counsel | XIn-the-money exercise Common Stock | +18,879 | $0.00 | $0 | 79,749 | Mar 6, 2023 |
| Mar 2, 2023 | VTRS Viatris Inc | Brian Roman Global General Counsel | XIn-the-money exercise Restricted Stock Unitsderivative | -5,034 | $0.00 | $0 | 0 | Mar 6, 2023 |
| Mar 2, 2023 | VTRS Viatris Inc | Brian Roman Global General Counsel | XIn-the-money exercise Restricted Stock Unitsderivative | -18,879 | $0.00 | $0 | 0 | Mar 6, 2023 |
| Feb 28, 2023 | KIO KKR Income Opportunities Fund | Michael E Cahill director | XIn-the-money exercise Common Stock | +917 | - | - | 8,250 | Mar 3, 2023 |
| Feb 28, 2023 | KIO KKR Income Opportunities Fund | Michael E Cahill director | XIn-the-money exercise Oversubscription Privilege (contingent right to buy)derivative | -917 | - | - | 0 | Mar 3, 2023 |
| Feb 27, 2023 | NYC American Strategic Investment Co. | Elizabeth K. Tuppeny director | XIn-the-money exercise Class A Common Stock | +864 | $12.95 | $11k | 5,385 | Mar 1, 2023 |
| Feb 27, 2023 | NYC American Strategic Investment Co. | Louis P. DiPalma director | XIn-the-money exercise Class A Common Stock | +523 | $12.95 | $6,773 | 2,561 | Mar 1, 2023 |
| Feb 27, 2023 | NYC American Strategic Investment Co. | Edward M Weil Jr. CEO, President and Secretary | XIn-the-money exercise Class A Common Stock | +1,361 | $12.95 | $18k | 2,887 | Mar 1, 2023 |
| Feb 27, 2023 | NYC American Strategic Investment Co. | Edward M Weil Jr. CEO, President and Secretary | XIn-the-money exercise Class A Common Stockindirect: See footnote | +129,859 | $12.95 | $1.7M | 275,351 | Mar 1, 2023 |
| Feb 28, 2023 | DCPH Deciphera Pharmaceuticals, Inc. | Brightstar Associates LLC owner | XIn-the-money exercise Common Stock | +2,427,693 | $0.01 | $24k | 22,145,707 | Mar 1, 2023 |
| Feb 28, 2023 | DCPH Deciphera Pharmaceuticals, Inc. | Brightstar Associates LLC owner | XIn-the-money exercise Warrants (right to buy)derivative | -2,427,693 | $0.00 | $0 | 962,137 | Mar 1, 2023 |
| Feb 21, 2023 | PRST Presto Automation Inc. | Dan Mosher CHIEF REVENUE OFFICER | XIn-the-money exercise Incentive Stock Optionderivative | -9,177 | $2.23 | $20k | 504,181 | Feb 23, 2023 |
| Feb 22, 2023 | PRST Presto Automation Inc. | Dan Mosher CHIEF REVENUE OFFICER | XIn-the-money exercise Incentive Stock Optionderivative | -5,627 | $2.23 | $13k | 498,554 | Feb 23, 2023 |
| Feb 22, 2023 | WINT WINDTREE THERAPEUTICS INC /DE/ | James Huang director | XIn-the-money exercise Common Stockindirect: See Footnote | +1,112,308 | $0.14 | $157k | 3,449,161 | Feb 23, 2023 |
| Feb 22, 2023 | WINT WINDTREE THERAPEUTICS INC /DE/ | James Huang director | XIn-the-money exercise Warrants (right to purchase)derivativeindirect: See Footnote | -1,112,308 | $0.00 | $0 | 0 | Feb 23, 2023 |
| Jan 27, 2023 | INRD Inrad Optics, Inc. | William J Foote director | XIn-the-money exercise Stock Optionderivative | +10,000 | $0.00 | $0 | 169,327 | Feb 22, 2023 |
| Feb 17, 2023 | RICK RCI HOSPITALITY HOLDINGS, INC. | ADW Capital Management, LLC owner | XIn-the-money exercise Common stock, $0.01 par valueindirect: See Footnotes | +50,000 | $30.00 | $1.5M | 949,000 | Feb 22, 2023 |
| Feb 17, 2023 | RICK RCI HOSPITALITY HOLDINGS, INC. | ADW Capital Management, LLC owner | XIn-the-money exercise Call Option (Right to Buy)derivativeindirect: See Footnotes | -500 | $0.00 | $0 | 0 | Feb 22, 2023 |
| Feb 17, 2023 | ATEC Alphatec Holdings, Inc. | L-5 Healthcare Partners, LLC owner, other | XIn-the-money exercise Warrants to Purchase Common Stockderivative | -2,346,032 | $0.00 | $0 | 0 | Feb 21, 2023 |
| Feb 16, 2023 | BLNK Blink Charging Co. | Michael D Farkas Chairman & CEO | XIn-the-money exercise Common Stock, par value $0.001 per share ("Common Stock") | +365,482 | $4.25 | $1.6M | 2,028,067 | Feb 21, 2023 |
| Feb 16, 2023 | BLNK Blink Charging Co. | Michael D Farkas Chairman & CEO | XIn-the-money exercise Warrants to purchase shares of Common Stockderivative | -365,482 | $0.00 | $0 | 0 | Feb 21, 2023 |
| Feb 16, 2023 | KIO KKR Income Opportunities Fund | Michael E Cahill director | XIn-the-money exercise Common Stock | +1,833 | - | - | 7,333 | Feb 21, 2023 |
| Feb 16, 2023 | KIO KKR Income Opportunities Fund | Michael E Cahill director | XIn-the-money exercise Transferable Subscription Right (right to buy)derivative | -5,500 | - | - | 0 | Feb 21, 2023 |
| Feb 16, 2023 | KIO KKR Income Opportunities Fund | Christopher A Sheldon other | XIn-the-money exercise Common Stock | +4,998 | - | - | 19,992 | Feb 21, 2023 |
| Feb 16, 2023 | KIO KKR Income Opportunities Fund | Christopher A Sheldon other | XIn-the-money exercise Transferable Subscription Right (right to buy)derivative | -14,994 | - | - | 0 | Feb 21, 2023 |
| Feb 16, 2023 | KIO KKR Income Opportunities Fund | Jeremiah S Lane other | XIn-the-money exercise Common Stock | +666 | - | - | 2,666 | Feb 21, 2023 |
| Feb 16, 2023 | KIO KKR Income Opportunities Fund | Jeremiah S Lane other | XIn-the-money exercise Transferable Subscription Right (right to buy)derivative | -2,000 | - | - | 0 | Feb 21, 2023 |
| Feb 16, 2023 | KBLB Kraig Biocraft Laboratories, Inc | Jonathan Richard Rice COO | XIn-the-money exercise Class A Common Stock Optionderivative | +2,434,211 | - | - | 500,000 | Feb 17, 2023 |
| Feb 14, 2023 | MCD MCDONALDS CORP | Edith Morgan Flatley EVP - Global CMO | XIn-the-money exercise Common Stock | +45 | $0.00 | $0 | 2,019 | Feb 15, 2023 |
| Feb 14, 2023 | MCD MCDONALDS CORP | Edith Morgan Flatley EVP - Global CMO | XIn-the-money exercise Dividend Equivalent Rightsderivative | -45 | $0.00 | $0 | 0 | Feb 15, 2023 |
| Feb 9, 2023 | MLAB MESA LABORATORIES INC /CO/ | John Sakys CFO | XIn-the-money exercise Non Qualified Stock Optionderivative | -1,000 | $0.00 | $0 | 26,702 | Feb 9, 2023 |
| Feb 1, 2023 | PLBY PLBY Group, Inc. | John Giampetroni owner | XIn-the-money exercise Common Stockindirect: See Footnote | +11,021,569 | $0.00 | $0 | 21,765,783 | Feb 3, 2023 |
| Feb 1, 2023 | PLBY PLBY Group, Inc. | John Giampetroni owner | XIn-the-money exercise Subscription Rights (rights to buy)derivativeindirect: See Footnote | -10,739,714 | $0.00 | $0 | 0 | Feb 3, 2023 |
| Feb 1, 2023 | PLBY PLBY Group, Inc. | Suhail Rizvi director, owner | XIn-the-money exercise Common Stockindirect: See Footnote | +11,021,569 | $0.00 | $0 | 21,765,783 | Feb 3, 2023 |
| Feb 1, 2023 | PLBY PLBY Group, Inc. | Suhail Rizvi director, owner | XIn-the-money exercise Subscription Rights (rights to buy)derivativeindirect: See Footnote | -10,739,714 | $0.00 | $0 | 0 | Feb 3, 2023 |
| Jan 31, 2023 | BIOF BLUE BIOFUELS, INC. | Edmund J Burke director | XIn-the-money exercise COMMON STOCK | +1,000,000 | $0.05 | $50k | 13,430,276 | Jan 31, 2023 |
| Jan 31, 2023 | BIOF BLUE BIOFUELS, INC. | Edmund J Burke director | XIn-the-money exercise COMMON STOCK | +4,450,148 | $0.01 | $22k | 13,430,276 | Jan 31, 2023 |
| Jan 31, 2023 | BIOF BLUE BIOFUELS, INC. | Edmund J Burke director | XIn-the-money exercise WARRANTSderivative | -1,000,000 | $0.05 | $50k | 0 | Jan 31, 2023 |
| Jan 31, 2023 | BIOF BLUE BIOFUELS, INC. | Edmund J Burke director | XIn-the-money exercise WARRANTSderivative | -4,450,148 | $0.01 | $22k | 0 | Jan 31, 2023 |
| Jan 25, 2023 | ATEC Alphatec Holdings, Inc. | L-5 Healthcare Partners, LLC owner, other | XIn-the-money exercise Warrants to Purchase Common Stockderivative | -2,000,000 | $0.00 | $0 | 2,346,032 | Jan 26, 2023 |
| Jan 23, 2023 | MLAB MESA LABORATORIES INC /CO/ | John Sakys CFO | XIn-the-money exercise Non Qualified Stock Optionderivative | -2,100 | $0.00 | $0 | 27,702 | Jan 25, 2023 |
| Jan 20, 2023 | BURU Nuburu, Inc. | Susquehanna Securities, LLC owner | XIn-the-money exercise Class A Common Stock | -372,500 | $10.00 | $3.7M | 71,069 | Jan 24, 2023 |
| Jan 20, 2023 | BURU Nuburu, Inc. | Susquehanna Securities, LLC owner | XIn-the-money exercise Class A Common Stock | +300 | $7.50 | $2,250 | 71,369 | Jan 24, 2023 |
| Jan 20, 2023 | BURU Nuburu, Inc. | Susquehanna Securities, LLC owner | XIn-the-money exercise Class A Common Stock | +20,200 | $12.50 | $253k | 91,569 | Jan 24, 2023 |
| Jan 20, 2023 | BURU Nuburu, Inc. | Susquehanna Securities, LLC owner | XIn-the-money exercise Put Option (right to sell)derivative | -3,725 | $0.00 | $0 | 0 | Jan 24, 2023 |
| Jan 20, 2023 | BURU Nuburu, Inc. | Susquehanna Securities, LLC owner | XIn-the-money exercise Put Option (obligation to buy)derivative | -3 | $0.00 | $0 | 44 | Jan 24, 2023 |
| Jan 20, 2023 | BURU Nuburu, Inc. | Susquehanna Securities, LLC owner | XIn-the-money exercise Put Option (obligation to buy)derivative | -202 | $0.00 | $0 | 0 | Jan 24, 2023 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.